Sony has begun teasing its next flagship true wireless earbuds, the WF-1000XM6, finally offering a first official hint after months of leaks and speculation.

Sony refers to the earbuds as the “next generation,” and flashes part of the design for just a moment. Still, it’s the clearest signal so far that the successor to the WF-1000XM5 is close.

Sony has confirmed that the full announcement will take place on February 12, 2026, at 16:00 UTC (9:30 PM IST). The company hasn’t said whether this will be a livestream or a simple press release, but full specifications are expected either way.

It has been almost three years since the WF-1000XM5 launched in July 2023, which is a longer gap than usual for Sony’s 1000X lineup. In that time, competition from Apple, Bose, and Sennheiser has only intensified, raising expectations around what the XM6 needs to deliver.

The design shown in the teaser appears to match recent leaks. The earbuds look more compact than before, moving away from the rounded shape of the XM5. The new form factor appears flatter and more pill-shaped, which could help with comfort and fit. The charging case also seems to have changed. It looks slimmer and more angular.

Leaks have also pointed to a few smaller but practical changes. A matte finish is expected to return, after some users complained about the glossy surface on the XM5. There also appears to be an extra microphone opening, which could be linked to improvements in active noise cancellation or call quality, though Sony hasn’t confirmed anything yet.

Colour options may expand slightly as well. Black and platinum silver have appeared in leaked images, and there are reports of a third colour, possibly Sand Pink.

With the announcement now just days away, Sony hasn’t left much room for surprises. Whether the WF-1000XM6 represents a major step forward or a more cautious update will become clear soon enough.

Don’t miss a thing! Join our Telegram community for instant updates and grab our free daily newsletter for the best tech stories!

For more daily updates, please visit our News Section.

(Source: Sony)

The post Sony confirms WF-1000XM6 launch date, teases new design appeared first on Gizmochina.

Smartwatches that claim to measure blood sugar without needles are once again under scrutiny, this time from Germany’s Federal Network Agency. In its latest market surveillance report, the regulator confirmed that several devices sold in 2025 advertised blood glucose tracking despite having no technical ability to measure it, which is a practice officials say poses real risks to consumers.

According to the agency, inspections carried out over the year uncovered problems across roughly 7.7 million electronic products. Many of the violations were procedural, such as missing CE markings or incomplete German-language documentation. Others, however, went far beyond paperwork. Among the most concerning findings were smartwatches that simulate blood sugar readings using unrelated sensors or estimated values, while presenting the results as genuine health data.

Why blood sugar tracking on smartwatches is misleading

Industry experts have been clear for years: accurate blood glucose monitoring requires either invasive testing or an external continuous glucose monitor (CGM). No standalone smartwatch can currently deliver reliable readings on its own. Despite this, low-cost models sold mainly through online marketplaces continue to market the feature aggressively, often targeting people with diabetes.

In at least some cases, the consequences could be serious. A previously published review of the Kospet iHeal 6 showed that its so-called glucose readings varied sharply from real measurements, sometimes enough to influence medication decisions. Regulators warn that relying on such data could lead users to delay insulin, overcorrect their dosage, or ignore warning signs altogether.

The scope of the issue remains significant. The agency flagged 1,266 online listings suspected of non-compliance. While this figure represents an 11.2% decline compared to the previous year, the products involved still accounted for an estimated five million units sold. Smartwatches were the most common offenders, not only for false health claims but also for violations of Germany’s Radio Equipment Act.

Offline inspections revealed similar problems. Of 2,400 device models checked at retail, 58% failed to meet regulatory standards, affecting around 1.9 million units. Most issues were administrative, though some products were found to emit excessive electromagnetic interference.

Customs authorities also stepped up enforcement, blocking 359,000 non-compliant devices at the border after examining more than 8,200 shipments.

For regulators, the message is straightforward: health claims must be backed by real technology. For consumers, Germany’s warning is a reminder that if a smartwatch promises needle-free blood sugar tracking, skepticism is not just reasonable, it’s necessary.

Don’t miss a thing! Join our Telegram community for instant updates and grab our free daily newsletter for the best tech stories!

For more daily updates, please visit our News Section.

(Source | Image)

The post Smartwatches fake blood sugar readings as 58% of inspected device models fail German checks appeared first on Gizmochina.